Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.
Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.
During the annual AASLD meeting that will take place in Boston, MA (November 8-12, 2019) our group has submitted five scientific abstracts, which have being accepted for presentation. This work ranges from discovery, to translation, and to clinical application. We are very excited to share with our followers this [...]
Clinical trials are an important aspect of our work as we try to find a medical therapy for patients suffering from Primary Sclerosing Cholangitis (PSC). To this end, we would like to inform the PSC community that Mayo Clinic in Rochester Minnesota is currently recruiting patients with [...]
On June 28, 2019 the Extramural Advisory Committee (EAC) of the Carlos Research Program in PSC met in Rochester, Minnesota for our annual scientific retreat.
The retreat included updates on our scientific programs, clinical trials, and operational initiatives. The Annual Update of the Carlos PSC Research Program is [...]
The majority of patients with the PSC have Inflammatory Bowel Disease (IBD). In this presentation, Dr. Laura Raffals, Associate Professor of Medicine, Mayo Clinic College of Medicine provides a comprehensive review of the epidemiology, diagnosis, outcomes and management of IBD among PSC patients.
View the [...]
Female patients with the PSC and inflammatory bowel disease (IBD) have unique health and disease issues to deal with.
During the 15th Annual Conference of the “PSC Partners Seeking a Cure”", Dr. Alina Allen, Assistant Professor of Medicine, Mayo Clinic College of Medicine, and Dr. Laura Raffals, Associate [...]